Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jan;45(1):327-30.
doi: 10.1128/AAC.45.1.327-330.2001.

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

S Arikan  1 , M Lozano-Chiu, V Paetznick, J H Rex
Affiliations

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

S Arikan et al. Antimicrob Agents Chemother. 2001 Jan.

Abstract

We investigated the relevance of prominent reduction in turbidity macroscopically (MIC) and formation of aberrant hyphal tips microscopically (minimum effective concentration; MEC) in measuring the in vitro activity of caspofungin against Aspergillus and Fusarium. Caspofungin generated low MICs and MECs against Aspergillus, but not for Fusarium. While MICs increased inconsistently when the incubation time was prolonged, MEC appeared as a stable and potentially relevant endpoint in testing in vitro caspofungin activity.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abruzzo G K, Flattery A M, Gill C J, Kong L, Smith J G, Bikounis V B, Balkovec J M, Bouffard A F, Dropinski J F, Rosen H, Kropp H, Bartizal K. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1997;41:2333–2338. - PMC - PubMed
    1. Abruzzo G K, Flattery A M, Gill C J, Kong L, Smith J G, Krupa D, Pkounis V B, Kropp H, Bartizal K. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1995;39:1077–1081. - PMC - PubMed
    1. Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex J H. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol. 1999;37:3946–3951. - PMC - PubMed
    1. Bartizal K, Gill C J, Abruzzo G K, Flattery A M, Kong L, Scott P M, Smith J G, Leighton C E, Bouffard A, Dropinski J F, Balkovec J. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) Antimicrob Agents Chemother. 1997;41:2326–2332. - PMC - PubMed
    1. Del Poeta M, Schell W A, Perfect J R. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob Agents Chemother. 1997;41:1835–1836. - PMC - PubMed

Publication types